Ardena, a pharmaceutical contract development and manufacturing organisation (CDMO), has announced an expansion of its bioanalytical services in the Netherlands. The investment includes a 3,000-square-foot lab at Pivot Park in Oss, expected to be operational by Q1 2025, alongside upgrades
Ardena announced a significant change in its leadership. Harry Christiaens, who has led the company as CEO for 20 years, is stepping down and will be succeeded by Jeremie Trochu. Christiaens will continue to serve on Ardena’s Board. Trochu is
Ardena, a Contract Development and Manufacturing Organisation (CDMO), has announced the receipt of Good Manufacturing Practice (GMP) approval from the Dutch Healthcare Authority for its new analytical laboratories. This approval is part of the company’s recent expansion of its nanomedicines
Ardena Contract Manufacturing & Development (CDMO) Profile Ardena is a fully integrated CDMO with a core focus on bringing molecules to the clinics. Our full-service offering covers: • Drug Substance: Navigating your small-molecule API project through route scouting, development and
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
